相关实验视频

Updated: Sep 4, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

人类淋巴细胞的血清类型与免疫血清获得后的homografting

R L WALFORD, R GALLAGHER, J R SJAARDA

    Science (New York, N.Y.)
    |May 15, 1964
    PubMed
    概括

    来自皮肤同种移植的人类血清显示出针对特定淋巴细胞的细胞毒性活性. 这种淋巴细胞的反应性似乎是遗传的,有可能识别人类基因相容性抗原.

    关键词:
    抗原 - 抗体反应血型 血型 血型 血型遗传学,人类免疫血清 免疫血清淋巴细胞 淋巴细胞皮肤移植 皮肤移植移植免疫学 移植免疫学

    更多相关视频

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    相关概念视频

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...